Medtech InsightGE HealthCare CEO Peter Arduini declared orders growth in each of the company’s four segments in Q4 2024, continuing the commercial progress made since its spin out from GE Corp as “the largest health
ScripJazz Pharmaceuticals plc has acquired near-global rights to a promising narcolepsy candidate from Japan’s Sumitomo Pharmaceuticals Europe Ltd. , paying $50m upfront at a time when some of its bigges